NCT02312076View on ClinicalTrials.gov

GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Infertility
Interventions
DRUG

Triptorelin

Luteal phase support will be continued by the same regimen started on the day of oocytes retrieval until 2 weeks after embryo transfer (ET) with subcutaneous administration of a single dose (0.2 mg) of GnRHa (Triptorelin) 6 days after oocyte retrieval

Trial Locations (2)

35111

RECRUITING

Fertility Care Unit (FCU) in Mansoura University Hospital, Al Mansurah

Unknown

RECRUITING

Private fertility care centers, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER